Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Louis Mas

Showing results (201-210 of 215) with videos related to

Pageof 22
Sort By:
Lancet (London, England)|September 5, 2022
Factor XIa inhibition with asundexian after acute non-cardioembolic ischaemic stroke (PACIFIC-Stroke): an international, randomised, double-blind, placebo-controlled, phase 2b trialAshkan Shoamanesh, Hardi Mundl, Eric E Smith, et al.
Neurology|November 6, 2016
Proportion of single-chain recombinant tissue plasminogen activator and outcome after strokeDidier Leys, Yannick Hommet, Clémence Jacquet, et al.
Stroke|December 19, 2013
Carotid stenting: is there an operator effect? A pooled analysis from the carotid stenting trialists' collaborationDavid Calvet, Jean-Louis Mas, Ale Algra, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|April 9, 2016
close: Closure of patent foramen ovale, oral anticoagulants or antiplatelet therapy to prevent stroke recurrence: Study designJean-Louis Mas, Geneviève Derumeaux, Pierre Amarenco, et al.
JAMA Neurology|April 14, 2020
Proposal for Updated Nomenclature and Classification of Potential Causative Mechanism in Patent Foramen Ovale-Associated StrokeAkram Y Elgendy, Jeffrey L Saver, Zahid Amin, et al.
European Heart Journal|January 28, 2021
European position paper on the management of patients with patent foramen ovale. Part II - Decompression sickness, migraine, arterial deoxygenation syndromes and select high-risk clinical conditionsChristian Pristipino, Peter Germonpré, Danilo Toni, et al.
Neurology|May 3, 2024
Patent Foramen Ovale Closure in Older Patients With Stroke: Patient Selection for Trial FeasibilityAndy Y Wang, Peter M Rothwell, Jason Nelson, et al.
The New England Journal of Medicine|September 14, 2017
Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after StrokeJean-Louis Mas, Geneviève Derumeaux, Benoît Guillon, et al.
Neurology|March 12, 2024
Statin Therapy for Secondary Prevention in Ischemic Stroke Patients With Cerebral MicrobleedsLuis Prats-Sanchez, Pol Camps-Renom, Philip S Nash, et al.
Journal of Neurointerventional Surgery|April 9, 2018
Association of follow-up infarct volume with functional outcome in acute ischemic stroke: a pooled analysis of seven randomized trialsAnna M M Boers, Ivo G H Jansen, Ludo F M Beenen, et al.
Pageof 22

Showing results (201-210 of 215) with videos related to

Sort By:
Pageof 22
Lancet (London, England)|September 5, 2022
Factor XIa inhibition with asundexian after acute non-cardioembolic ischaemic stroke (PACIFIC-Stroke): an international, randomised, double-blind, placebo-controlled, phase 2b trialAshkan Shoamanesh, Hardi Mundl, Eric E Smith, et al.
Neurology|November 6, 2016
Proportion of single-chain recombinant tissue plasminogen activator and outcome after strokeDidier Leys, Yannick Hommet, Clémence Jacquet, et al.
Stroke|December 19, 2013
Carotid stenting: is there an operator effect? A pooled analysis from the carotid stenting trialists' collaborationDavid Calvet, Jean-Louis Mas, Ale Algra, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|April 9, 2016
close: Closure of patent foramen ovale, oral anticoagulants or antiplatelet therapy to prevent stroke recurrence: Study designJean-Louis Mas, Geneviève Derumeaux, Pierre Amarenco, et al.
JAMA Neurology|April 14, 2020
Proposal for Updated Nomenclature and Classification of Potential Causative Mechanism in Patent Foramen Ovale-Associated StrokeAkram Y Elgendy, Jeffrey L Saver, Zahid Amin, et al.
European Heart Journal|January 28, 2021
European position paper on the management of patients with patent foramen ovale. Part II - Decompression sickness, migraine, arterial deoxygenation syndromes and select high-risk clinical conditionsChristian Pristipino, Peter Germonpré, Danilo Toni, et al.
Neurology|May 3, 2024
Patent Foramen Ovale Closure in Older Patients With Stroke: Patient Selection for Trial FeasibilityAndy Y Wang, Peter M Rothwell, Jason Nelson, et al.
The New England Journal of Medicine|September 14, 2017
Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after StrokeJean-Louis Mas, Geneviève Derumeaux, Benoît Guillon, et al.
Neurology|March 12, 2024
Statin Therapy for Secondary Prevention in Ischemic Stroke Patients With Cerebral MicrobleedsLuis Prats-Sanchez, Pol Camps-Renom, Philip S Nash, et al.
Journal of Neurointerventional Surgery|April 9, 2018
Association of follow-up infarct volume with functional outcome in acute ischemic stroke: a pooled analysis of seven randomized trialsAnna M M Boers, Ivo G H Jansen, Ludo F M Beenen, et al.
Pageof 22